Severe COVID-19 Disables Disease-Fighting Immune Circuit
Patients with severe COVID-19 produce antibodies that paradoxically shut down their immune system’s virus-fighting response just when they need it most.
University of California San Francisco
Give to UCSF
Comprehensive Parnassus Heights Plan Moves Forward After UC Regents Vote
The Regents’ vote follows more than two years of robust community engagement spanning 28 public meetings to develop the CPHP, which reflects input from hundreds of stakeholders inside and outside UCSF.
UCSF Experts Among Highlights at 2021 Precision Medicine World Conference Focused on COVID-19
Scientific presentations will include advances in understanding the immune response, and precision medicine-driven development of new diagnostics, therapeutics, vaccines, and population health strategies.
COVID-19 Predictions for 2021 and Beyond
Few would have predicted last January that a pandemic would upend our daily lives. But one grueling year in, UCSF experts have a clearer view of the path ahead.
COVID-19 Variant First Found in Other Countries and States Now Seen More Frequently in California
“It’s too soon to know if this variant will spread more rapidly than others," said Erica Pan, MD, MPH, State Epidemiologist for the California Department of Public Health.
Personalized Brain Stimulation Alleviates Severe Depression Symptoms
Depression is among the most common psychiatric disorders, affecting as many as 264 million people worldwide and leading to hundreds of thousands of deaths per year. But as many as 30 percent of patients do not respond to standard treatments such as medication or psychotherapy.
Community Workforce Agreement for Parnassus Project is Boon for Local Jobs, Economy
UCSF, the San Francisco Building and Construction Trades Council, and Herrero Boldt Webcor have announced a Community Workforce Agreement that will promote collaboration between the University, labor unions and construction firms during the construction of the new hospital at UCSF Helen Diller Medical Center at Parnassus Heights.
Virus Versus Virus: ‘ReScan’ Antibody Test is a Powerful New Tool
Scientists at UCSF have developed ReScan, an innovative new serological test that employs a specialized version of the technique known as phage display.
How Worried Should You Be About the New Coronavirus Variant?
A mutated version of the novel coronavirus has been making the news for being more contagious. We asked UCSF infectious disease expert Charles Chiu, MD, PhD, how the new variant emerged, whether available vaccines will still work, and what we need to do now.
Brain Cells Most Vulnerable to Alzheimer’s Disease Identified by Scientists
A team of researchers has identified for the first time the neurons that are among the first victims of Alzheimer’s disease.
UCSF Administers Second Dose of COVID-19 Vaccine to Frontline Staff
UCSF Medical Center has begun administering second doses of the Pfizer COVID-19 vaccine to frontline employees who are at highest risk of exposure to COVID-19 at work.
